跳至主要内容
临床试验/NCT02579161
NCT02579161已完成3 期

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

Northwell Health2 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
98
试验地点
2
主要终点
Number of Participants With Infectious Complications

研究概览

简要总结

The Investigators objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. The investigator hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes.

详细描述

For large renal stone burdens and/or complex stones, Percutaneous Nephrolithotomy (PCNL) has become the mainstay for treatment, replacing open kidney stone surgery since it's introduction in 1976. However, PCNL is not without its complications, specifically infectious. The procedure carries up to 25% incidence of infectious complications with approximately 1% rate of severe sepsis even with completely sterile conditions. Therefore, the use of antibiotics becomes paramount, but to date there are no PNCL specific guidelines for the appropriate duration and class of antibiotics. This fact leaves the practicing urologists to their own subjective experiences to the guide them. In addition, in an age where there are increasing numbers of resistant microbes the judicious use of antibiotics is in even more paramount.

The investigators of this project, purpose a randomized intention to treat prospective study to explore the duration and type of antibiotics in a larger population then previously studied. The investigators hypothesize that there will be no difference in complications between two groups: 1) 24 hours of perioperative antibiotics versus 2) Continued antibiotics until the removal of any external catheters. The investigators will model the antibiotics choices and duration after the 2013 American Urological Association, (AUA) Urologic Surgery Antimicrobial Prophylaxis recommendations, modified by our local antibiogram as necessary. The investigators' objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. Our hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes.

Antibiotic detail: cephalosporins or aminoglycoside + metronidazole or clindamycin and the alternative for allergies being aminoglycoside/ sulbactam or fluoroquinolone

Looking at the same drugs and doses the variable is the timeframe of the medication

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years old
  • Negative urine culture within 1 month prior to procedure
  • Renal Calculi which would optimally require PCNL for treatment.

排除标准

  • Patients <18 years old.
  • Patients who are not able to give consent for study
  • Patients currently on antibiotics immediately prior to the procedure
  • Previous history of sepsis or SIRS from stone manipulations
  • Foley catheter in place for greater than 1 week duration
  • Patients under going planned, multi-staged procedures
  • Immunosuppressed patients

研究组 & 干预措施

Antibiotics for a 24 hour period

Active Comparator

Antibiotics for a 24 hour period

Intervention drug to be determined based on patient history etc.

干预措施: cephalosporins (Drug)

Antibiotics for a 24 hour period

Active Comparator

Antibiotics for a 24 hour period

Intervention drug to be determined based on patient history etc.

干预措施: Fluoroquinolones (Drug)

Antibiotics for a 24 hour period

Active Comparator

Antibiotics for a 24 hour period

Intervention drug to be determined based on patient history etc.

干预措施: Clindamycin (Drug)

Antibiotics for a 24 hour period

Active Comparator

Antibiotics for a 24 hour period

Intervention drug to be determined based on patient history etc.

干预措施: Ampicillin/Gentamicin (Drug)

Continued antibiotics

Active Comparator

Continued antibiotics until the removal of any external catheters

Intervention drug to be determined based on patient history etc.

干预措施: cephalosporins (Drug)

Continued antibiotics

Active Comparator

Continued antibiotics until the removal of any external catheters

Intervention drug to be determined based on patient history etc.

干预措施: Fluoroquinolones (Drug)

Continued antibiotics

Active Comparator

Continued antibiotics until the removal of any external catheters

Intervention drug to be determined based on patient history etc.

干预措施: Clindamycin (Drug)

Continued antibiotics

Active Comparator

Continued antibiotics until the removal of any external catheters

Intervention drug to be determined based on patient history etc.

干预措施: Ampicillin/Gentamicin (Drug)

结局指标

主要结局

Number of Participants With Infectious Complications

时间窗: 0-30 days post-operatively

Compare the rate of infectious complications following a single-dose of peri-operative protocol (antibiotics for 24 hours as recommended by the American Urological Association Guidelines) with a short-course protocol (antibiotics continued until any external catheters such as nephrostomy tubes are removed) following percutaneous nephrolithotomy. Complication rate differences, primarily infectious complications such as fever, sepsis, systemic inflammatory response.

次要结局

  • Length of Stay (Days)(0-30 days post operatively)
  • Number of Participants With Associated Clavien Grade of Adverse Event(0 to 30 days after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验